Chris Swanson is one of the first participants in the latest HIV vaccine trial. He spoke with me about his experiences with HIV, his experiences with the trial, and why he chose to participate.
This is David Nalos, Social Media Specialist at the HIV Research Section at the San Francisco Department of Public Health, and I wanna welcome you to the first Trials and Vials Podcast. The HIV Research Section is a leader in HIV Prevention Research working with Bay Area communities to discover effective prevention strategies that will reduce the impact of HIV/AIDS globally. Today we’re talking to Chris Swanson, one of the first participants in the latest HIV vaccine trial.
How are you Chris?
Chris: I’m doing very very well, thank you.
David: So let’s talk HIV. Now, HIV, as you know, has been around for almost 30 years now and for almost as long we’ve been trying to find a vaccine to end the epidemic. So tell me why did you decide to join the trial and why now. Why is now the right time?